Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00923377 · ClinicalTrials.gov registry record
Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 3
- Enrollment target
NCT00923377: Completed study, sponsored by National Cancer Institute (NCI).
NCT00923377 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00923377 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
Background: * Research suggests that breast cancers may arise from a population of stem cells in the normal mammary gland that produce clones of cancer cells. * Researchers are now trying to determine what events may initiate the formation of cancer cells. Objectives: * To look for and describe breast stem cells from normal breast tissue from women who do not have breast cancer. * To compare the breast stem cells between women at increased risk for breast cancer and women at average risk for breast cancer. * To show a relationship between the number and type of breast stem cells with the density (appearance) of the mammogram (breast x-ray). * To make cell cultures (grow cells under controlled conditions) from the breast stem cells. Eligibility: -Women 18 years of age and older who are at average or increased risk for breast cancer. Design: Participants complete a health history questionnaire, family history questionnaire and risk assessment questionnaire. * Participants have a mammogram and breast biopsy (surgical removal of a sample of breast tissue). * Women who can become pregnant have a urine pregnancy test....
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2007-03-23 |
| Est. Completion | 2010-05-11 |
What the finished NCT00923377 record still lists
NCT00923377 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00923377 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00923377 about?
NCT00923377 is a clinical study titled "Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer". Background: * Research suggests that breast cancers may arise from a population of stem cells in the normal mammary gland that produce clones of cancer cells. * Researchers are now trying to determine what events may initiate the formation of cancer cells. Objectives: * To look for and describe b...
What is the current status of trial NCT00923377?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2007-03-23. Estimated completion is 2010-05-11.
Who is sponsoring clinical trial NCT00923377?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI